Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001731122-24-000138
Filing Date
2024-01-24
Accepted
2024-01-24 16:05:09
Documents
2
Group Members
RS GROUP APS

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A4 e5374_sc13da4.htm SC 13D/A 57431
2 EXHIBIT 1 e5374_ex-1.htm EX-1 6432
  Complete submission text file 0001731122-24-000138.txt   65592
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-86428 | Film No.: 24556425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FRUEBJERGVEJ 3 BOX 62 COPENHAGEN G7 2100
Business Address
Sindlev Rene (Filed by) CIK: 0001709513 (see all company filings)

Type: SC 13D/A